Guerin Mark Patrick 4
4 · Onconova Therapeutics, Inc. · Filed Feb 9, 2024
Insider Transaction Report
Form 4
Guerin Mark Patrick
Chief Accounting Officer
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-02-07−6,900→ 6,900 total→ Common Stock (6,900 underlying) - Exercise/Conversion
Common Stock
2024-02-07+6,900→ 32,344 total - Tax Payment
Common Stock
2024-02-07$0.67/sh−2,443$1,637→ 29,901 total
Footnotes (2)
- [F1]Restricted stock units convert into common stock on a one-for-one basis.
- [F2]On February 7, 2022 the reporting person was granted 20,700 restricted stock units which vest over 3 years from the date of grant: 33% on the first anniversary; 33% on the second anniversary; and 34% on the third anniversary.